Bicara Therapeutics BCAX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $96.69M-80.3% | $489.71M+113% | $230.44M+5,442% | ||
| $318.12M— | $0— | —— | ||
| $422.05M-16.0% | $502.53M+117% | $231.07M— | ||
| $330K+113% | $155K-23.3% | $202K— | ||
| $430.99M-15.5% | $510M+118% | $233.98M— | ||
| $28.95M+60.9% | $17.99M+19.3% | $15.09M— | ||
| $29.54M+63.0% | $18.12M+17.1% | $15.47M— | ||
| 500M+7,142,757% | 7K+250% | 2K— | ||
| -$358.97M-62.4% | -$221.02M-44.4% | -$153.02M— | ||
| $401.45M-18.4% | $491.88M+431% | -$148.77M-50.6% | ||
| $430.99M-15.5% | $510M+118% | $233.98M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bicara Therapeutics's total assets?
- Bicara Therapeutics (BCAX) holds $553.6M in total assets, up 15.8% year over year.
- How much debt does Bicara Therapeutics have?
- Bicara Therapeutics carries $1.4M in total debt against $514.0M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Bicara Therapeutics have?
- Bicara Therapeutics holds $323.5M in cash and equivalents.
- Can Bicara Therapeutics cover its short-term obligations?
- Its current ratio is 13.85 — current assets exceed current liabilities.
- Where does Bicara Therapeutics's balance sheet data come from?
- Every line is extracted from Bicara Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.